Call to members, from your Society ’s President

The Society for Endocrinology has been looking at itsstrategic goals to identify our key priorities over the next few years. Last year’s membership survey showed that the Society needs to do more work to recruit and retain the next generation of researchers, clinicians and nurses within our discipline. We now need your help. To identify what we can do to make the most difference in two specific areas, Council have set uptwo working groups for which we are seeking members:To look at how we bestattract and then support research scientists within endocrinology. Chair: Eleanor Davies, General Secretary-ElectTo further develop the concept of a new programme for early career members, that aims torecognise and nurture emerging talent, supporting the future leaders of endocrinology. Chair: Graham Williams, PresidentThe aim of the working groups will be to consider a number of questions/ suggestions related to the above, and recommend to Council, in December 2018, a series of initiatives that the Society can implement. Working groups will primarily hold discussions throughout 2018 via teleconference, though may occasionally meet face to face. We are looking for all types of members at all career stages to take part.If you would like to take part in either working group and would like further details, please emailLaura Udakis, Director of Membership Engagement, byMonday 19 March.Thanks for contributing to the future of your Society.
Source: Society for Endocrinology - Category: Endocrinology Source Type: news

Related Links:

The Diabetes Empowerment Summit is a free virtual conference taking place May 1-5, 2019, that offers many mental health resources for coping with diabetes.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
Background/Aims: Peptide receptor radionuclide therapy (PRRT) is becoming clinical routine for management of Neuroendocrine Tumours. The number of PRRT cycles are correlated with treatment effect but theoretically limited by off-target radiation damage to kidneys and bone marrow. New imaging biomarkers for assessment of PRRT tissue damage would enable evaluation of novel renal and bone marrow protective agents, as well as personalized PRRT treatment regiments. Methods: Mice treated with [177Lu]Lu-DOTA-TATE PRRT or vehicle were examined at baseline and following treatment with [18F]FLT PET and [99mTc]Tc-Mag3 SPECT to asses...
Source: Neuroendocrinology - Category: Endocrinology Source Type: research
Source: Journal of Investigative Dermatology - Category: Dermatology Source Type: research
Source: Journal of Investigative Dermatology - Category: Dermatology Source Type: research
Source: Journal of Investigative Dermatology - Category: Dermatology Source Type: research
These authors from Hungary highlight that no studies to date have employed the EuroQol EQ-5D questionnaire to assess health-related quality of life (HRQoL) in patients with pemphigus. Their aim with this study was to evaluate the HRQoL of patients with pemphigus by the EQ-5D and to analyse the convergent and known-groups validity of the EQ-5D in this patient population. To do this they carried out a multicentre cross-sectional study between 2014 and 2017. Their outcome measures included the five-level EQ-5D, Dermatology Life Quality Index, Autoimmune Bullous Skin Disorder Intensity Score and an average pain-intensity visua...
Source: Journal of Investigative Dermatology - Category: Dermatology Tags: Editorial Source Type: research
Editorial note: Welcome to the Journal of Investigative Dermatology (JID) Cells to Surgery Quiz. In this monthly online-only quiz, the first question relates to the clinical image above, while additional questions concern the findings reported in a JID article by Olsen et  al. (https://dx.doi.org/10.1016/j.jid.2018.09.022) that provides new information about that disease entity.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Cells to Surgery Quiz Source Type: research
A key factor that determines the applicability of trial evidence to clinical guidelines is the choice of outcomes. In an evaluation of 10  Cochrane Skin systematic reviews and 220 clinical trials, Schmitt and colleagues found a low degree of agreement between trial and review outcomes. A significant number of outcomes sought by reviews were not assessed in dermatological trials, potentially introducing weakness in systematic review c onclusions. Better concordance was observed between the trials and reviews for outcome domains, fortuitously suggesting that trialists and reviewers typically consider similar aspects of disease.
Source: Journal of Investigative Dermatology - Category: Dermatology Tags: Editorial Source Type: research
Observational evidence indicates a relationship between increased body mass index (BMI) and psoriasis, but the direction of causality remains unclear. Using mendelian randomization, which randomly allocates individuals to groups based on genotype, of more than 750,000 individuals from large population-based and genome-wide association studies, Budu-Aggrey and colleagues demonstrated that higher BMI causally increases the odds of psoriasis occurrence. This increase is likely to be clinically significant because a 1 kg/m2 increase in BMI increases the odds of psoriasis by 9%.
Source: Journal of Investigative Dermatology - Category: Dermatology Tags: Editorial Source Type: research
Editorial note: Welcome to the Journal of Investigative Dermatology (JID) SnapshotDx Quiz. In this monthly online-only quiz, the first question ( “What is your diagnosis?”) relates to the clinical image above, while additional questions concern the findings reported in a JID article by Zaalberg et al. (https://dx.doi.org/10.1016/j.jid.2018.03.1522).
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: SnapshotDx Quiz Source Type: research
More News: Endocrinology | Nurses | Nursing